Cargando…

Pharmacogenetics – Challenges and Opportunities Ahead

Detalles Bibliográficos
Autor principal: Zanger, Ulrich M.
Formato: Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095373/
https://www.ncbi.nlm.nih.gov/pubmed/21607063
http://dx.doi.org/10.3389/fphar.2010.00112
_version_ 1782203641318342656
author Zanger, Ulrich M.
author_facet Zanger, Ulrich M.
author_sort Zanger, Ulrich M.
collection PubMed
description
format Text
id pubmed-3095373
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-30953732011-05-23 Pharmacogenetics – Challenges and Opportunities Ahead Zanger, Ulrich M. Front Pharmacol Pharmacology Frontiers Research Foundation 2010-08-20 /pmc/articles/PMC3095373/ /pubmed/21607063 http://dx.doi.org/10.3389/fphar.2010.00112 Text en Copyright © 2010 Zanger. http://www.frontiersin.org/licenseagreement This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Pharmacology
Zanger, Ulrich M.
Pharmacogenetics – Challenges and Opportunities Ahead
title Pharmacogenetics – Challenges and Opportunities Ahead
title_full Pharmacogenetics – Challenges and Opportunities Ahead
title_fullStr Pharmacogenetics – Challenges and Opportunities Ahead
title_full_unstemmed Pharmacogenetics – Challenges and Opportunities Ahead
title_short Pharmacogenetics – Challenges and Opportunities Ahead
title_sort pharmacogenetics – challenges and opportunities ahead
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095373/
https://www.ncbi.nlm.nih.gov/pubmed/21607063
http://dx.doi.org/10.3389/fphar.2010.00112
work_keys_str_mv AT zangerulrichm pharmacogeneticschallengesandopportunitiesahead